{"id":1749,"date":"2022-07-23T14:21:56","date_gmt":"2022-07-23T14:21:56","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1749"},"modified":"2026-02-23T00:47:12","modified_gmt":"2026-02-23T00:47:12","slug":"a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/","title":{"rendered":"A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr)"},"content":{"rendered":"

Currently, fewer than 1 in 5 women with breast cancer are eligible for NHS testing for inherited gene changes. This information can inform treatment of breast cancer, as well as enabling patients and their family members to better understand their future risks of developing cancer. One of the main limiting factors is availability of expert clinical staff to discuss the implications of testing and the results. This paper presents a study of a new digital \u2018BRCA-DIRECT\u2019 pathway for pre-test information, consent and return of results, which is supported by a genetic counsellor specialist telephone hotline. The findings from the pilot phase of 150 women offer preliminary evidence that this digital pathway is feasible, safe and acceptable to breast cancer patients. (https:\/\/jmg.bmj.com\/content\/early\/2022\/07\/22\/jmg-2022-108655<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Currently, fewer than 1 in 5 women with breast cancer are eligible for NHS testing for inherited gene changes. This information can inform treatment of breast cancer, as well as enabling patients and their family members to better understand their future risks of developing cancer. One of the main limiting factors is availability of expert […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1749","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nA digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Currently, fewer than 1 in 5 women with breast cancer are eligible for NHS testing for inherited gene changes. This information can inform treatment of breast cancer, as well as enabling patients and their family members to better understand their future risks of developing cancer. One of the main limiting factors is availability of expert [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-23T14:21:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T00:47:12+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2022\\\/07\\\/23\\\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2022\\\/07\\\/23\\\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr)\",\"datePublished\":\"2022-07-23T14:21:56+00:00\",\"dateModified\":\"2026-02-23T00:47:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2022\\\/07\\\/23\\\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\\\/\"},\"wordCount\":144,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2022\\\/07\\\/23\\\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2022\\\/07\\\/23\\\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2022\\\/07\\\/23\\\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\\\/\",\"name\":\"A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2022-07-23T14:21:56+00:00\",\"dateModified\":\"2026-02-23T00:47:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2022\\\/07\\\/23\\\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2022\\\/07\\\/23\\\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2022\\\/07\\\/23\\\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/","og_locale":"en_US","og_type":"article","og_title":"A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr) - JMG Contact blog","og_description":"Currently, fewer than 1 in 5 women with breast cancer are eligible for NHS testing for inherited gene changes. This information can inform treatment of breast cancer, as well as enabling patients and their family members to better understand their future risks of developing cancer. One of the main limiting factors is availability of expert [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/","og_site_name":"JMG Contact blog","article_published_time":"2022-07-23T14:21:56+00:00","article_modified_time":"2026-02-23T00:47:12+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr)","datePublished":"2022-07-23T14:21:56+00:00","dateModified":"2026-02-23T00:47:12+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/"},"wordCount":144,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/","url":"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/","name":"A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2022-07-23T14:21:56+00:00","dateModified":"2026-02-23T00:47:12+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2022\/07\/23\/a-digital-pathway-for-genetic-testing-in-uk-nhs-cancer-patients-brca-direct-study-internal-pilot\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT study internal pilot (Contributed by Bethany Torr)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1749"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1749\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}